1-10 of 10
Fumito Ito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors

Takaaki Oba, Ryutaro Kajihara, Toshihiro Yokoi, Elizabeth A. Repasky, Fumito Ito
Journal: Cancer Research
Cancer Res (2021) 81 (24): 6183–6195.
https://doi.org/10.1158/0008-5472.CAN-21-0939
Published: 15 December 2021
View articletitled, Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors
Open the PDF for Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract 1044: Frequency of circulating CX3CR1+ CD8+ T cells to predict response to immune checkpoint inhibitor therapy

Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Kristopher Attwood, Sebastiano Battaglia, Igor Puzanov, Hongbin Chen, Grace Dy, Brahm Segal, Marc Ernstoff, Fumito Ito
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1044.
https://doi.org/10.1158/1538-7445.AM2020-1044
Published: 15 August 2020
View articletitled, Abstract 1044: Frequency of circulating CX3CR1+ CD8+ T cells to predict response to immune checkpoint inhibitor therapy
Journal Articles

Abstract P5-04-03: Conversion of non-T cell-inflamed triple-negative breast cancer by in situ immunomodulation of induced intratumoral cross-presenting dendritic cells

Takaaki Oba, Tibor Keler, Henry C Marsh, Scott Abrams, Fumito Ito
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-04-03.
https://doi.org/10.1158/1538-7445.SABCS19-P5-04-03
Published: 15 February 2020
View articletitled, Abstract P5-04-03: Conversion of non-T cell-inflamed triple-negative breast cancer by in situ immunomodulation of induced intratumoral cross-presenting dendritic cells
Journal Articles

Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory

Hidehito Saito, Keisuke Okita, Alfred E. Chang, Fumito Ito
Journal: Cancer Research
Cancer Res (2016) 76 (12): 3473–3483.
https://doi.org/10.1158/0008-5472.CAN-15-1742
Published: 14 June 2016
View articletitled, Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory
Open the PDF for Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory in another window
Includes: Supplementary data
Journal Articles

Abstract 5011: generation of rejuvenated murine antigen-specific T cells by reprogramming to pluripotency and redifferentiation

Fumito Ito, Noemi Fusaki, Hidehito Saito
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5011.
https://doi.org/10.1158/1538-7445.AM2015-5011
Published: 01 August 2015
View articletitled, Abstract 5011: generation of rejuvenated murine antigen-specific T cells by reprogramming to pluripotency and redifferentiation
Journal Articles

Abstract 1358: Generation of induced pluripotent stem cells from tumor-infiltrating lymphocytes

Hidehito Saito, Keisuke Okita, Noemi Fusaki, Michael Sabel, Alfred Chang, Fumito Ito
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1358.
https://doi.org/10.1158/1538-7445.AM2015-1358
Published: 01 August 2015
View articletitled, Abstract 1358: Generation of induced pluripotent stem cells from tumor-infiltrating lymphocytes
Journal Articles

Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines

Fumito Ito, Qiao Li, Andrew B. Shreiner, Ryuji Okuyama, Maria N. Jure-Kunkel, Seagal Teitz-Tennenbaum, Alfred E. Chang
Journal: Cancer Research
Cancer Res (2004) 64 (22): 8411–8419.
https://doi.org/10.1158/0008-5472.CAN-04-0590
Published: 17 November 2004
View articletitled, Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines
Open the PDF for Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines in another window
Journal Articles

Anti-CD137 antibody administration polarizes T cells activated by tumor-lysate pulsed dendritic cells via NK cells.

Fumito Ito, Qiao Li, Andrew B. Shreiner, Ryuji Okuyama, Alfred E. Chang
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 505–506.
Published: 01 April 2004
View articletitled, Anti-CD137 antibody administration polarizes T cells activated by tumor-lysate pulsed dendritic cells via NK cells.
Journal Articles

Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration

Seagal Teitz-Tennenbaum, Qiao Li, Susan Rynkiewicz, Fumito Ito, Mary A. Davis, Cornelius J. Mcginn, Alfred E. Chang
Journal: Cancer Research
Cancer Res (2003) 63 (23): 8466–8475.
Published: 16 December 2003
View articletitled, Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration
Open the PDF for Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration in another window
Journal Articles

Polarization Effects of 4-1BB during CD28 Costimulation in Generating Tumor-reactive T Cells for Cancer Immunotherapy

Qiao Li, Abbey Carr, Fumito Ito, Seagal Teitz-Tennenbaum, Alfred E. Chang
Journal: Cancer Research
Cancer Res (2003) 63 (10): 2546–2552.
Published: 15 May 2003
View articletitled, Polarization Effects of 4-1BB during CD28 Costimulation in Generating Tumor-reactive T Cells for Cancer Immunotherapy
Open the PDF for Polarization Effects of 4-1BB during CD28 Costimulation in Generating Tumor-reactive T Cells for Cancer Immunotherapy in another window